1. Home
  2. EVN vs CADL Comparison

EVN vs CADL Comparison

Compare EVN & CADL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Eaton Vance Municipal Income Trust

EVN

Eaton Vance Municipal Income Trust

HOLD

Current Price

$10.21

Market Cap

430.6M

Sector

Finance

ML Signal

HOLD

Logo Candel Therapeutics Inc.

CADL

Candel Therapeutics Inc.

HOLD

Current Price

$5.01

Market Cap

357.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EVN
CADL
Founded
N/A
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Bankers/Brokers/Service
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
430.6M
357.4M
IPO Year
1998
2021

Fundamental Metrics

Financial Performance
Metric
EVN
CADL
Price
$10.21
$5.01
Analyst Decision
Strong Buy
Analyst Count
0
8
Target Price
N/A
$19.00
AVG Volume (30 Days)
96.0K
1.2M
Earning Date
01-01-0001
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
58.62
EPS
N/A
N/A
Revenue
N/A
$125,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$9.59
$4.25
52 Week High
$11.23
$7.24

Technical Indicators

Market Signals
Indicator
EVN
CADL
Relative Strength Index (RSI) 36.34 48.13
Support Level $10.31 $4.56
Resistance Level $11.15 $5.42
Average True Range (ATR) 0.15 0.24
MACD -0.01 0.04
Stochastic Oscillator 31.07 66.03

Price Performance

Historical Comparison
EVN
CADL

About EVN Eaton Vance Municipal Income Trust

Eaton Vance Municipal Income Trust is a United States-based diversified, closed-end management investment company. Its investment objective is to provide current income exempt from regular federal income tax. The trust's portfolio of investments majorly consists of debt instruments of governments, municipal organizations the interest on which is exempt from regular federal income tax and has also some exposure to corporate bonds and other instruments.

About CADL Candel Therapeutics Inc.

Candel Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing off-the-shelf viral immunotherapies that elicit an individualized, systemic anti-tumor immune response to help patients fight cancer. The immune cells induced by these viral immunotherapies are believed to target patients' specific tumor antigens, potentially improving responses in immunologically hot tumors while at the same time infiltrating the tumor microenvironment, transforming non-inflamed cold tumors with limited immune response into hot tumors. The company has established two clinical off-the-shelf viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.

Share on Social Networks: